Stem Cell poised to give entrenched Modern Medicine a run for its money

New Delhi: Stem Cell therapy is all set to become mainstream medicine as this non surgical and minimally invasive technology is making medical world sit up and notice by its success stories one after another. The 3 days Stem Cell Xpress Kumbh of its practitioners and scientists was an unmistakable testimony to this. The seemingly eye popping claim of reversing Diabetes in just 7 days turned out the biggest draw of the conference.

The therapeutic potential of Stem Cell was asserted in loud and clear terms in the conference. The speakers were bullish that stem cell is going to be the future of medicine. StemCellXpress, International Conference on Stem Cell, Regenerative Medicine and Anti-Ageing and workshops scripted a runaway success as participants outnumbered all previous stem cell congregations in the city. Cosmostem Institute of Regenerative Aesthetic Medicine and StemGenn Therapeutics conducted stem cell training.

Dr Prabhu Mishra, ace stem cell scientist and founder of StemGenn Therapeutics, straddled across the scene as s colossus of the emerging technology. Talking to Medicare News, Dr Mishra, Organising Secretary, said, ‘The conference marks a turning point in the realm of stem cell based regenerative medicine. The market for this breakthrough medicine In India is pegged to grow at 20-25 percent annually and reach USD146 million by2021.’

‘In India, the environment is conducive for the growth of this effective technology as the economy is growing well and the number of families with disposable is rising. Indians can particularly take advantage of Regenerative Medicine as people here prefer non surgical and non invasive procedures which this medical breakthrough is, said Dr Mishra, CEO, StemGenn Therapeutics.’

‘The market for cosmetic procedures for enhancement of looks and face is about to explode in India and dentists, dermatologists and orthopaedic doctors can top up their practice with solutions that Stem Cell Therapy entail,’ added Dr. Mishra.

Scientists and clinicians from around the globe belonging to different medical realms like stem cell transplantation, metabolic medicine, cosmetic gynecology, cell based aesthetics, ortho biologics, therapeutic cloning, tissue engineering and regenerative medicine focussed on various medical solutions like reversing diabetes in 7 days, regeneration of joints as a viable alternative for replacement, rejuvenation of ovary among post-menopausal women to have their own eggs enabling pregnancy, stem cell therapy for vascular and auto-immune disease, vaginal rejuvenation, application of mesenchymal stem cell to detect parental genetic disease, fat reduction and various anti-ageing mechanisms.

‘A whopping 425 million people worldwide are living with diabetes and India accounts for about half of the global burden. The incidence is expected to jump significantly in the next 5-10 years. We need effective and lasting solution to the problem of diabetes and Stem Cell Therapy is a bright ray of hope. This Therapy can prevent the microvascular complications of diabetes by managing it,” said Dr. Graham Simpsom, Scientific Advisor, StemGenn Therapeutics.

Related Posts

Bee might have bared Fangs like Death for Karishma Kapoor’s Ex Hubby

It is assumed bee bite could have triggered fatal heart attack in Sanjay Kapoor Delhi/London:  It is not a wild guess that bee sting might have caused fatal heart attack…

FUJIFILM resolves to detect Breast Cancer early with Apollo Hospitals

Telugu Actor Ram Charan’s Wife & Apollo Patriarch’s Scion acts as Ambassador Hyderabad:  FUJIFILM India, a leader in healthcare technology, has launched its latest CSR campaign, ‘Find It Early, Fight…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Novo Nordisk launches blockbuster weight-loss drug Wegovy in India; Check price, dosage and other details

Novo Nordisk launches blockbuster weight-loss drug Wegovy in India; Check price, dosage and other details

Aurobindo Pharma arm gets marketing authorization in UK for Dyrupeg

Aurobindo Pharma arm gets marketing authorization in UK for Dyrupeg

Sun Pharma’s European partner withdraws application for skin cancer treatment therapy

Sun Pharma’s European partner withdraws application for skin cancer treatment therapy

Glenmark Pharma launches TEVIMBRA in India

Glenmark Pharma launches TEVIMBRA in India